This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

For India to compete, it must transition from being the “pharmacy of the world” to the “innovation engine of the world.” ...

Instead, pharmacy benefit managers — which determine ... Commission that aim to use the courts to force PBMs to change practices that drive up drug prices. It’s not only insulin.

The FDA issued a warning letter to Sanofi regarding significant manufacturing violations at its Genzyme Corporation Facility in Framingham, Mass. The letter, dated Dec. 16, 2024, and amended Jan.